Contract with Customer, Liability, Current of BIO-TECHNE Corp from 30 Jun 2018 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.
Summary
BIO-TECHNE Corp quarterly Contract with Customer, Liability, Current in USD history and change rate from 30 Jun 2018 to 30 Sep 2025.
  • BIO-TECHNE Corp Contract with Customer, Liability, Current for the quarter ending 30 Sep 2025 was $30,445,000, a 14% increase year-over-year.
Source SEC data
View on sec.gov
Contract with Customer, Liability, Current, Quarterly (USD)
Contract with Customer, Liability, Current, YoY Quarterly Change (%)

BIO-TECHNE Corp Quarterly Contract with Customer, Liability, Current (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $30,445,000 +$3,831,000 +14% 30 Sep 2025 10-Q 05 Nov 2025 2026 Q1
Q2 2025 $32,571,000 +$4,641,000 +17% 30 Jun 2025 10-Q 05 Nov 2025 2026 Q1
Q1 2025 $32,269,000 +$2,161,000 +7.2% 31 Mar 2025 10-Q 08 May 2025 2025 Q3
Q4 2024 $27,715,000 -$712,000 -2.5% 31 Dec 2024 10-Q 06 Feb 2025 2025 Q2
Q3 2024 $26,614,000 +$2,098,000 +8.6% 30 Sep 2024 10-Q 05 Nov 2024 2025 Q1
Q2 2024 $27,930,000 +$4,861,000 +21% 30 Jun 2024 10-K 22 Aug 2025 2025 FY
Q1 2024 $30,108,000 +$5,230,000 +21% 31 Mar 2024 10-Q 06 May 2024 2024 Q3
Q4 2023 $28,427,000 +$6,615,000 +30% 31 Dec 2023 10-Q 07 Feb 2024 2024 Q2
Q3 2023 $24,516,000 +$2,457,000 +11% 30 Sep 2023 10-Q 07 Nov 2023 2024 Q1
Q2 2023 $23,069,000 -$337,000 -1.4% 30 Jun 2023 10-K 22 Aug 2024 2024 FY
Q1 2023 $24,878,000 +$1,771,000 +7.7% 31 Mar 2023 10-Q 08 May 2023 2023 Q3
Q4 2022 $21,812,000 +$2,731,000 +14% 31 Dec 2022 10-Q 07 Feb 2023 2023 Q2
Q3 2022 $22,059,000 +$2,938,000 +15% 30 Sep 2022 10-Q 07 Nov 2022 2023 Q1
Q2 2022 $23,406,000 +$4,411,000 +23% 30 Jun 2022 10-K 23 Aug 2023 2023 FY
Q1 2022 $23,107,000 +$4,393,000 +23% 31 Mar 2022 10-Q 09 May 2022 2022 Q3
Q4 2021 $19,081,000 +$5,864,000 +44% 31 Dec 2021 10-Q 07 Feb 2022 2022 Q2
Q3 2021 $19,121,000 +$5,836,000 +44% 30 Sep 2021 10-Q 08 Nov 2021 2022 Q1
Q2 2021 $18,995,000 +$5,946,000 +46% 30 Jun 2021 10-K 24 Aug 2022 2022 FY
Q1 2021 $18,714,000 +$5,158,000 +38% 31 Mar 2021 10-Q 07 May 2021 2021 Q3
Q4 2020 $13,217,000 +$1,324,000 +11% 31 Dec 2020 10-Q 08 Feb 2021 2021 Q2
Q3 2020 $13,285,000 +$4,177,000 +46% 30 Sep 2020 10-Q 09 Nov 2020 2021 Q1
Q2 2020 $13,049,000 +$3,965,000 +44% 30 Jun 2020 10-K 25 Aug 2021 2021 FY
Q1 2020 $13,556,000 +$3,444,000 +34% 31 Mar 2020 10-Q 11 May 2020 2020 Q3
Q4 2019 $11,893,000 +$3,497,000 +42% 31 Dec 2019 10-Q 06 Feb 2020 2020 Q2
Q3 2019 $9,108,000 +$346,000 +3.9% 30 Sep 2019 10-Q 06 Nov 2019 2020 Q1
Q2 2019 $9,084,000 +$975,000 +12% 30 Jun 2019 10-K 26 Aug 2020 2020 FY
Q1 2019 $10,112,000 31 Mar 2019 10-Q 07 May 2019 2019 Q3
Q4 2018 $8,396,000 31 Dec 2018 10-Q 07 Feb 2019 2019 Q2
Q3 2018 $8,762,000 30 Sep 2018 10-Q 07 Nov 2018 2019 Q1
Q2 2018 $8,109,000 30 Jun 2018 10-K/A 06 Nov 2019 2019 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.